Abstract
Background
The association of hyperthyroidism with renal disease is very rare and the importance of timely clinical recognition cannot be overemphasized.
Case presentation
An 11-year-old girl presented with gastrointestinal symptoms while hypertension, edema and abdominal pain were noticed on clinical examination. Laboratory investigation revealed: hemoglobin 9.4 (11.5–15.5) g/dL, total white cell count 16 (4.5–12)×109/L, platelets 247 (150–450)×109/L, C-reactive protein (CRP) 31.8 (<5) mg/L, blood urea nitrogen (BUN) 126 (13–43) mg/dL, creatinine 0.98 (0.53–0.79) mg/dL, albumin 25 (35–52) g/dL, complement factor C3 0.7 (0.9–1.8) g/L, complement factor C4 0.1 (0.1–0.4) g/L, tri-iodothyronine 6.5 (2.5–5.2) pg/mL, free thyroxine 2.4 (1–1.7) ng/dL, thyroid stimulating hormone (TSH) <0.02 (0.5–4.3) mU/L. Urinalysis showed nephrotic range proteinuria. Renal function deteriorated necessitating hemodialysis (HD). A renal biopsy revealed an immune complex-mediated membranoproliferative glomerulonephritis (MPGN). Elevated thyroid hormones and suppressed TSH levels with elevated thyroperoxidase antibodies and thyroid stimulating immunoglobulins confirmed the diagnosis of Graves’ disease. Corticosteroids were commenced and eventually thiamazole was added with gradual improvement of renal function, cessation of HD and discharge from the hospital.
Conclusions
Graves’ disease complicated by MPGN is extremely rare, but can cause life-threatening complications.
Author contributions: All the authors have accepted responsibility for the entire content of this submitted manuscript and approved submission.
Research funding: None declared.
Employment or leadership: None declared.
Honorarium: None declared.
Competing interests: The funding organization(s) played no role in the study design; in the collection, analysis, and interpretation of data; in the writing of the report; or in the decision to submit the report for publication.
References
1. Ito S, Kano K, Ando T, Ichimura T. Thyroid function in children with nephrotic syndrome. Pediatr Nephrol 1994;8:412–5.10.1007/BF00856516Search in Google Scholar PubMed
2. Sethi S, Fervenza FC. Membranoproliferative glomerulonephritis – a new look at an old entity. N Engl J Med 2012;366:1119.10.1056/NEJMra1108178Search in Google Scholar PubMed
3. Fervenza F, Sanjeev Sethi S. Clinical presentation, classification, and causes of membranoproliferative glomerulonephritis. Available at: https://www.uptodate.com/contents/clinical-presentation-classification-and-causes-of-membranoproliferative-glomerulonephritis?source=see_link. Accessed: 24 Apr 2017.Search in Google Scholar
4. Rennke HG. Secondary membranoproliferative glomerulonephritis. Kidney Int 1995;47:643–56.10.1038/ki.1995.82Search in Google Scholar PubMed
5. Gurkan S, Dikman S, Saland MJ. A case of autoimmune thyroiditis and membranoproliferative glomerulonephritis. Pediatr Nephrol 2009;24:193–7.10.1007/s00467-007-0668-ySearch in Google Scholar PubMed
6. Valentín M, Bueno B, Gutiérrez E. Membranoproliferative glomerulonephritis associated with autoimmune thyroiditis. [Article in Spanish] Nefrologia 2004;24(Suppl 3):43–8.Search in Google Scholar
7. Zand L, Fervenza FC, Nasr SH, Sethi S. Membranoproliferative glomerulonephritis associated with autoimmune diseases. J Nephrol 2014;27:165–71.10.1007/s40620-014-0049-0Search in Google Scholar PubMed
8. Weetman AP, Tomlinson K, Amos N, Lazarus JH, Hall R, et al. Proteinuria in autoimmune thyroid disease. Acta Endocrinol (Copenh) 1985;109:341–7.10.1530/acta.0.1090341Search in Google Scholar PubMed
9. Singh I, Hershman JM. Pathogenesis of hyperthyroidism. Compr Physiol 2016;7:67–79.10.1002/cphy.c160001Search in Google Scholar PubMed
10. Mackel SE, Jordon RE. Leukocytoclastic vasculitis. A cutaneous expression of immune complex disease. Arch Dermatol 1982;118:296–301.10.1001/archderm.118.5.296Search in Google Scholar PubMed
©2018 Walter de Gruyter GmbH, Berlin/Boston
